COVID-19 Diagnostics Market Segmented by Application and Geography Trends, Growth and Forecasts to 2030
COVID-19 diagnostics are the emerging diagnostic sets that are increasingly delivered to medical physicians to facilitate testing outside laboratories. These diagnostics kit is developed due to the increasing prevalence of COVID-19 positive patients. The pandemic impacted in shortage of laboratory-based testing capacities reagents. Owing to this, several diagnostic test manufacturers have launched and are selling faster and convenient devices for testing. These diagnostic kits are based on detection of proteins from Coronavirus in patients' respiratory samples like sputum and throat swab, or detection in serum or blood of antibodies created in response to the infection. The test developers have taken efforts to develop COVID-19 diagnostic kits that are today helping the medical physicians in treating the increasing number of suspected and the affected patients.The outbreak of Coronavirus worldwide has created lockdown situation in key regions. Increasing number of COVID-19 positive patients is ultimately stimulating the demand for efficient diagnostic kits. This requirement from healthcare physicians across the globe is creasing opportunity for more production of diagnostic kits to be delivered to various healthcare settings. Hence, diagnostic companies are shining during the ongoing pandemic with heavy demand for diagnostic testing kits. This will also impact on the research activities for the introduction of more efficient tools and devices that will help tackle the current epidemic.Major Key Players of the COVID-19 Diagnostics Market are:Seegene Inc., F. Hoffmann-La Roche Ltd, altona Diagnostics GmbH, SD BIOSENSOR, Abbott, BIOMEDOMICS INC., Bio-Rad Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Sensing Self, PTE. Ltd, Thermo Fisher Scientific, PerkinElmer Inc., among others.
No comments:
Post a Comment